A healthcare professional (hcp) for a clinical study reported via a representative that there was a diagnosis of device infection which required hospitalization.The patient presented and was admitted to the hospital on (b)(6) 2016 for increased swelling and pain surrounding implanted right chest battery device following surgery insertion on (b)(6) 2016.Blood tests showed raised crf (corticotrophin-releasing hormone) of 105 and normal white cell count; intravenous (iv) flucloxacillin was commenced on (b)(6) 2016.The patient was transferred and admitted to another hospital on (b)(6) 2016 and was assessed by hcps for further treatment and infection control advice, including blood tests and iv antibiotics.Device site infection was diagnosed on (b)(6) 2016 with some mild erythema and swelling around the battery site.On (b)(6) 2016, the patient was discharged.Follow-up appointments with the hcps occurred on (b)(6) 2016.The iv antibiotics, which were administered from (b)(6) 2016 until discharge, settled the erythema and swelling.The patient remained on oral antibiotics since discharge and had a follow-up appointment scheduled for (b)(6) 2016.The outcome was described as ¿continuing¿ but the event did not require device removal.Relationship to device was ¿probable.¿.
|